Investment
Features
FeesSafety
Academy
More
Pluang+

Compare First Citizens BancShares Inc (FCNCA) vs McKesson Corporation (MCK) Price & Performance

First Citizens BancShares IncTrade
McKesson CorporationTrade

Price performance (Past 24H)

Key statistics

First Citizens BancShares Inc vs McKesson Corporation — how do they compare? First Citizens BancShares Inc trades at $2,256.93 (market cap $25.04B), while McKesson Corporation trades at $895.52 (market cap $105.14B). The key difference: McKesson Corporation is far larger — about 4.2× First Citizens BancShares Inc's market cap, and McKesson Corporation pays the higher dividend (0.42%). Which is the better fit depends on your goals.

FCNCAMCK
Market Cap
$25.04B$105.14B
Sector
Sector/ThematicHealth
52-Week High
$2.25K$995.69
52-Week Low
$1.64K$659.01
Dividend Yield
0.37%0.42%
Enterprise Value
$111.67B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

First Citizens BancShares Inc

No Aura AI signal available yet.

McKesson Corporation

McKesson (MCK) trades at $879.87, up 1.18% today, with strong momentum from recent earnings beats and raised guidance. The stock shows bullish technical signals, supported by robust revenue growth and solid cash flow generation. Recent news highlights strength in specialty drugs and oncology, driving positive sentiment.

Outlook remains favorable with a consensus price target of $990.67, though thin profit margins and high liabilities pose risks. Continued execution on growth initiatives and cost discipline are key for sustained upside, while macroeconomic pressures and competitive dynamics require monitoring.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About First Citizens BancShares Inc

First Citizens BancShares is a major US regional bank providing diverse financial services. It recently expanded significantly by acquiring the assets and liabilities of Silicon Valley Bank.

Read more on FCNCA

About McKesson Corporation

McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.

Read more on MCK